Compare NUVB & BLBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NUVB | BLBD |
|---|---|---|
| Founded | 2018 | 1927 |
| Country | United States | United States |
| Employees | 307 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Construction/Ag Equipment/Trucks |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.3B |
| IPO Year | N/A | 2013 |
| Metric | NUVB | BLBD |
|---|---|---|
| Price | $5.83 | $77.38 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 6 |
| Target Price | $11.38 | ★ $68.00 |
| AVG Volume (30 Days) | ★ 8.9M | 424.6K |
| Earning Date | 05-04-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 22.78 |
| EPS | N/A | ★ 1.84 |
| Revenue | N/A | ★ $1,480,099,000.00 |
| Revenue This Year | $203.82 | $5.87 |
| Revenue Next Year | $58.18 | $6.83 |
| P/E Ratio | ★ N/A | $42.48 |
| Revenue Growth | N/A | ★ 9.87 |
| 52 Week Low | $2.06 | $42.00 |
| 52 Week High | $9.75 | $81.51 |
| Indicator | NUVB | BLBD |
|---|---|---|
| Relative Strength Index (RSI) | 57.36 | 57.69 |
| Support Level | $5.26 | $48.63 |
| Resistance Level | $6.06 | $81.07 |
| Average True Range (ATR) | 0.42 | 2.91 |
| MACD | 0.00 | -0.16 |
| Stochastic Oscillator | 41.34 | 60.39 |
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in different stages of development. The Company generates revenue from out-licensing collaborative agreements, including product revenue, upfront license fees, royalty revenue, and research and development services revenue. The Company generates the majority of its revenue from Japan.
Blue Bird Corp is an American bus manufacturing company. It is an independent designer and manufacturer of school buses. The company operates in two segments; the Bus segment which involves the design, engineering, manufacture, and sales of school buses and extended warranties; and the Parts segment which includes the sales of replacement bus parts. Geographically, the company generates a majority of its revenue from its customers in the United States and the rest from Canada and Rest of the world.